Resilience, Stress, and the Neurobiology of Aging
The aging of the world’s populations represents one of the most remarkable success stories in medicine and of humankind, but it is also a source of various challenges.
The aging of the world’s populations represents one of the most remarkable success stories in medicine and of humankind, but it is also a source of various challenges. Getting older can be stressful because of multiple losses (eg, interpersonal, financial) and a decline in health, independence, and cognitive and functional abilities.
Worldwide, human life expectancy has increased steadily for nearly 200 years and this trend is expected to continue. In every decade of the past century, life expectancy increased by about 2 years. This increase was driven in the first decades by improvements in sanitation, housing, and education. A steady decline in early and midlife mortality was mostly the result of our ability to prevent and treat infections. The increase in life expectancy in the latter half of the century was almost entirely attributable to a decline in late-life mortality secondary to medical advances and improved socioeconomic conditions.1
Many older adults are living longer with chronic illnesses yet are making the best of their later years. As George E. Vaillant2 pointed out in his book Aging Well, “The major factors involved in negative personality change at midlife are the same factors that caused negative aging at 70: bad habits, bad marriage, maladaptive defenses, and disease.”
The benefits of a positive outlook
Empirical evidence now supports the long-held belief that positive emotions are good for one’s health. Fredrickson’s “broaden-and-build theory” shows how positive emotions contribute to psychological and physical well-being through more effective coping.3,4 It is a natural drive to seek personal happiness and fulfillment regardless of age. Successful aging is associated with a positive psychological outlook in later years, general well-being, and happiness.2,5-7
With global trends in population aging, many nations are developing and implementing healthy aging policies to promote quality of life and additional years of health.7 One direction is to improve resilience to stress.
Depp and Jeste6 have defined resilience as “the ability to maintain biological and psychological homeostasis under stress. It may vary with context, time, age, gender, and cultural origin. Inquiry into resilience has evolved from descriptions of resilient qualities to uncovering the process of resilient adaptation. In older adults, resilience has been studied mostly in the context of successful aging (eg, in centenarians) or in the context of recovery from injury or illness.” The question remains whether resilience can be operationalized and taught to older stressed individuals and whether any interventions exist that boost resilience to stress and life’s adversities.
CHECKPOINTS
- Human responsiveness to stress may be attenuated by learned or adaptive skills, retraining, or increased resilience to future stress
- Physiological mediators such as adrenaline from the adrenal medulla, glucocorticoids from the adrenal cortex, and cytokines from the cells of the immune system act on receptors in various tissues and organs to produce effects that are adaptive to stress in the short run but can be damaging if the mediators are not shut off when no longer needed
- Prospective determinants of resilience for future studies include neuroendocrine, immunological, neural, genetic, temperamental, and environmental influences.
Stress and aging
Selye8 coined the term “stress” to define the alarm reaction, the stage of resistance, and the stage of exhaustion in animals and in humans. Only when the subject is overwhelmed or derailed does the stress response system begin to cause disease.9 Exposure to stress can be characterized in several ways: duration (acute, chronic), responsiveness (adaptive, hyperadaptive, nonresponsive), and severity (mild, moderate, extreme).10
Human responsiveness to stress may be attenuated by learned or adaptive skills, retraining, or indifference to future stress. The hypothalamic-pituitary-adrenal axis can be up regulated by a stressful experience, with increased amounts of circulating glucocorticoids, catecholamines, serotonin, and cytokines. These acute responses can lead to pathological changes that may be amplified by the aging of the brain.10
The adaptive physiological response to acute stress that involves internal milieu adjustment to change in the environment was initially described by Sterling and Eyer.11 McEwen12 extended this definition to include the concept of a set point that changes because of the process of maintaining homeostasis in the body that is mediated by the neuroendocrine, autonomic nervous, and immune systems. Allostasis is the term used to describe this process of “maintaining stability through change.”
Physiological mediators such as adrenaline from the adrenal medulla, glucocorticoids from the adrenal cortex, and cytokines from the cells of the immune system act on receptors in various tissues and organs to produce effects that are adaptive in the short run. If the mediators are not shut off when no longer needed, they can lead to deleterious effects of chronic stress, including receptor desensitization and tissue damage.
Aging can contribute to poor responsivity to stress because of reduced resilience.13 Accumulation of wear and tear caused by daily experiences and major life stressors can interact with genetic constitution and predisposing early life experiences to produce individual differences in the age-related diseases.10,13,14
Immunity, inflammation, and aging
The plasma concentrations of inflammatory mediators, such as cytokines and acute phase proteins, increase with aging, which results in low-grade inflammation. These changes lead to increased obesity and adiposity; a decrease in production of sex steroids; subclinical infections; and chronic aging-related disorders, such as cardiovascular disease and arthritis. Furthermore, aging is associated with a dysregulated cytokine response following stimulation.15
Several inflammatory mediators, such as tumor necrosis factor-α and interleukin-6 (IL-6), have the potential to induce and/or aggravate risk factors in age-associated pathology. Inflammatory mediators are also strong predictors of mortality independent of other known risk factors in elderly cohorts. For example, a proinflammatory factor IL-6 has been linked with Alzheimer disease, osteoporosis, rheumatoid arthritis, cardiovascular disease, and some forms of cancer, and it has been prospectively associated with general disability and mortality in large population-based studies.16-21
Neural circuitry and resilience
Brain imaging promotes understanding of brain regulation of positive emotions and resilience.22 The brain circuitry that is involved in emotional regulation includes several areas of the prefrontal cortex (PFC), amygdala, hippocampus, and anterior cingulate. The PFC plays a crucial role in the anticipation of future affective consequences of action as well as in the persistence of emotion.22
There are several different functional divisions of the PFC, including the dorsolateral, ventromedial, and orbital sectors. Each of these regions plays a different role in emotional regulation. The amygdala appears to be crucial for learning new stimulus-threat contingencies and to be important in the expression of cue-specific fear.23 Tonic activation and phasic reactivity in this circuit play an important role in governing different aspects of anxiety. Asymmetries within the PFC and activation of the amygdala are responsible for individual differences in affective style.22,23 Plasticity in this circuitry has implica-tions for cultivating positive affect and resilience.22,23
Resilience and aging
A coherent pattern of individual characteristics associated with resilience and successful adaptation has emerged. Salient characteristics include commitment, dynamism, humor in the face of adversity, patience, optimism, faith, and altruism.24 There are emotional and cognitive aspects of resilience that can be innate or learned. The innate affective or emotional styles that are likely to influence resilience refer to the individual styles of affect regulation, which are usually a part of personality structure (eg, optimism or pessimism), or social intelligence.
Temperament appears to be one of the determinants of resilience that is, at least, partially heritable. Protective temperamental factors include sociability, intelligence, social competence, internal locus of control, warmth and closeness of affectional ties, and active emotional support within the family network or within religious groups.25 As such, resilience may represent an important target for treatment and prevention of anxiety, depression, and abnormal stress reactions in aging persons (Figure).
Well-being and aging
A sense of well-being is an important characteristic of successful aging. Ryff and colleagues26 described 2 types of well-being: eudaimonic and hedonic. The aristotelian concept of eudaimonic well-being addresses ideas of self-development and self-acceptance, personal growth, positive relationships, and purposeful engagement. Hedonic well-being is concerned with positive feelings, such as happiness and contentment.
A sense of ill-being refers to all negative affect states, such as depression and anxiety. Different biological markers, including neuroendocrine (cortisol, epinephrine, norepinephrine), immune (IL-6, vaccine antibody response), cardiovascular (blood pressure, waist-hip ratio, cholesterol, glycosylated hemoglobin), sleep (duration/latency of rapid eye movement), and neural circuitry (cerebral asymmetry), are associated with the states of well-being or ill-being.26 The question remains whether resilience is responsible for the differences.
Psychotherapeutic and psychopharmacological approaches
Little research exists on preventive strategies to enhance resilience to stress in older adults. There are a few examples of the cognitive-behavioral therapy approach to resilience and well-being in younger adults. The resiliency training program is a 5-day progressive program that provides experiences for participants to enhance personal resilience.27 Select aspects of resilience that improve as a result of the intervention include self-esteem, locus of control, purpose in life, and interpersonal relations.
Fava and colleagues28-31 used well-being therapy (a short-term psychotherapeutic strategy) to improve symptoms of anxiety and depression in younger adults. Well-being therapy is based on a multidimensional model that encompasses environmental mastery, personal growth, purpose in life, autonomy, self-acceptance, and positive relations with others.7,26,32 It has been used as a relapse-preventive strategy in mood disorders and in treatment-resistant patients.28-30,33 Complementary and alternative interventions can also help treat or prevent stress-related disorders. Mind-body interventions, such as tai chi and meditation, have also been noted to modulate the immune response.34-37 These interventions can normalize immune and endocrine response to stress and depression. Relaxation and stress reduction can change the immune system by decreasing negative emotions. These interventions may influence immunity by providing people with more social contact or helping them develop better coping strategies.38,39
Physical exercise may be an effective intervention for limiting the impact of stress on immunity in chronically stressed older populations.40 Stress management interventions attempt to alleviate the immune system dysregulation that accompanies psychological stress.
Observations from an ongoing study of yoga meditation by family caregivers of patients with dementia have shown that meditation for 25 to 30 minutes can be strikingly beneficial (H. Lavretsky, unpublished data, 2010). Study participants report relief from depression and insomnia and improved coping ability.
Case vignette
A 65-year-old African American woman who was caring for her mother with Alzheimer disease and her sister with stroke-related dementia had significant depressive symptoms and distress and scored 12 on the Hamilton Depression Rating Scale (HDRS). Her symptoms began to diminish after she began to meditate daily; after 2 weeks her HDRS score decreased to 1. She reported an increased ability to cope and assess her stressful situation more objectively without the level of anger and resentment that was present before she started meditating. She also learned to allocate time to herself and take part in pleasurable activities. She no longer felt trapped or a victim of the circumstances.
For this stressed caregiver, daily meditation and the recognition of her psychological needs increased her resilience and ability to cope with her life stressors. This woman felt empowered by the idea of wellness, resilience, and self-reliance.
A recently published review of the effect of mindfulness meditation on cellular aging suggests that mindful meditation techniques shift cognitive appraisals from threat to challenge, decrease ruminative thought, reduce stress arousal, and directly increase positive arousal states that affect telomerase activity and telomere length, thereby improving longevity.41 Further studies are needed because currently there is only preliminary evidence that the use of mind-body techniques such as meditation can be useful in preventing diseases of aging.
Antidepressants have also been shown to promote resilience in patients with posttraumatic stress disorder (PTSD) and in stressed caregivers.42,43 Connor and colleagues43 undertook a 12-week placebo-controlled trial of fluoxetine in civil-ians with PTSD and reported better efficacy with fluoxetine than with placebo.
Pooled results from 2 large, multicenter, randomized, controlled trials of patients with PTSD using extended-release venlafaxine indicated that total Connor-Davidson Resilience scale scores and treatment were significant predictors of both response and remission.44
In our randomized placebo-controlled pilot study, 10 mg/d of citalopram improved resilience and decreased levels of depression and distress.42 This is the first trial of an antidepressant directed toward increasing resilience in a high-risk group of chronically stressed older caregivers. Preliminary results of our study of the complementary use of tai chi to augment treatment response in elderly depressed patients who had a partial response to 10 mg/d of escitalopram show improvement in psychological resilience and a decline in inflammatory markers (ie, C-reactive protein).
Conclusion
Research on resilience has shifted the focus of investigation from the illness-based approach to the well-being–oriented approach. A pattern of positive characteristics that could target new interventions to promote successful aging include sound intellectual functioning, the ability to handle emotions, self-esteem, optimism, altruism, humor, and an engaged and active coping style. Prospective biological markers of resilience important for future investigations include neuroendocrine, immunological, neural, genetic, temperamental, and environmental influences.
Resilience can be quantified by using standardized assessments in neurobiological and treatment studies. Multimodal assessment of the biological determinants of resilience will help identify targets for intervention to enhance resilience on both individual and cultural levels. Learning to enhance psychological resilience may help overcome health problems and their resulting disabilities.
Successful stress reduction and management, particularly among the most vulnerable seniors, can prevent serious mental and physical illness. Integrated modalities to improve resilience and reduce stress in combination with pharmacotherapy and lifestyle changes are likely to improve the overall functioning and well-being of older adults.
References:
References
1. Dominguez LJ, Barbagallo M, Morley JE. Anti-aging medicine: pitfalls and hopes. Aging Male. 2009;12:13-20.
2. Vaillant GE. Aging Well. Surprising Guidepost to a Happier Life From the Landmark Harvard Study of Adult Development. New York: Little, Brown and Co; 2002:373.
3. Fredrickson BL. The role of positive emotions in positive psychology. The broaden-and-build theory of positive emotions. Am Psychol. 2001;56:218-226.
4. Fredrickson BL, Joiner T. Positive emotions trigger upward spirals toward emotional well-being. Psychol Sci. 2002;13:172-175.
5. Rowe JW, Kahn RL. Successful Aging. New York: Dell Publishing; 1999:265.
6. Depp CA, Jeste DV. Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry. 2006;14:6-20.
7. Peel NM, McClure RJ, Bartlett HP. Behavioral determinants of healthy aging. Am J Prev Med. 2005;28:298-304.
8. Selye H. The Stress of Life. New York: McGraw-Hill; 1956.
9. McEwen BS. The End of Stress as We Know It. Washington, DC: National Academies Press; 2004:239.
10. Miller MM, McEwen BS. Establishing an agenda for translational research on PTSD. Ann N Y Acad Sci. 2006;1071:294-312.
11. Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J, eds. Handbook of Life Stress, Cognition, and Health. New York: John Wiley & Sons; 1988:629-649.
12. McEwen BS. Sex, stress, and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging. 2002;23:921-939.
13. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: McArthur studies of successful aging. Proc Natl Acad Sci U S A. 2001;98:4770-4775.
14. Karlamangla AS, Singer BH, McEwen BS, et al. Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. J Clin Epidemiol. 2002;55:696-710.
15. Black S, Humphrey JH, Niven JS. Inhibition of the Mantoux reaction by direct suggestion under hypnosis. Br Med J. 1963;1:1649-1652.
16. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993;41:176-181.
17. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639-646.
18. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad SciU S A. 2003;100:9090-9095.
19. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39:687-699.
20. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127-137.
21. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
22. Davidson RJ. Affective style, psychopathology, and resilience: brain mechanisms and plasticity. Am Psychol. 2000;55:1196-1214.
23. Davidson RJ. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry. 2002;51:68-80.
24. Lavretsky H, Irwin MR. Resilience and aging. Aging Health. 2007;3:309-323.
25. Werner EE. The children of Kaui: resiliency and recovery in adolescence and adulthood. J Adolesc Health. 1992;13:262-268.
26. Ryff CD, Singer BH, Dienberg Love G. Positive health: connecting well-being with biology. Philos Trans R Soc Lond B Biol Sci. 2004;359:1383-1394.
27. Richardson GE, Waite PJ. Mental health promotion through resilience and resiliency education. Int J Emerg Ment Health. 2002;4:65-75.
28. Fava GA, Rafanelli C, Cazzaro M, et al. Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med. 1998;28:475-480.
29. Fava GA, Ruini C, Rafanelli C, et al. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004;161:1872-1876.
30. Fava GA, Ruini C, Rafanelli C, et al. Well-being therapy of generalized anxiety disorder. Psychother Psychosom. 2005;74:26-30.
31. Ruini C, Belaise C, Brombin C, et al. Well-being therapy in school settings: a pilot study. Psychother Psychosom. 2006;75:331-336.
32. Ryff CD, Singer BH. Flourishing under fire: resilience as a prototype of challenged thriving. In: Keyes CL, Haidt J, eds. Flourishing: Positive Psychology and the Life Well-Lived. Washington, DC: American Psychological Association; 2003:15-36.
33. Fava GA. Well-being therapy: conceptual and technical issues. Psychother Psychosom. 1999;68:171-179.
34. Miller GE, Cohen S. Psychological interventions and the immune system: a meta-analytic review and critique. Health Psychol. 2001;20:47-63.
35. Irwin M, Pike J, Oxman M. Shingles immunity and health functioning in the elderly: tai chi chih as a behavioral treatment. Evid Based Complement Alternat Med. 2004;1:223-232.
36. Irwin MR, Olmstead R, Oxman MN. Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi. J Am Geriatr Soc. 2007;55:511-517.
37. Motivala SJ, Sollers J, Thayer J, Irwin MR. Tai chi chih acutely decreases sympathetic nervous system activity in older adults. J Gerontol A Biol Sci Med Sci. 2006;61:1177-1180.
38. Lutgendorf SK, Antoni MH, Kumar M, Schneiderman N. Changes in cognitive coping strategies predict EBV-antibody titre change following a stress-or disclosure induction. J Psychosom Res. 1994;38:63-78.
39. Segerstrom SC, Taylor SE, Kemeny ME, Fahey JL. Optimism is associated with mood, coping, and immune change in response to stress. J Pers Soc Psychol. 1998;74:1646-1655.
40. Phillips AC, Burns VE, Lord JM. Stress and exercise: getting the balance right for aging immunity. Exerc Sport Sci Rev. 2007;35:35-39.
41. Epel E, Daubenmier J, Moskowitz JT, et al. Can meditation slow rate of cellular aging? Cognitive stress, mindfulness, and telomeres. Ann N Y Acad Sci. 2009;1172:34-53.
42. Lavretsky H, Siddarth P, Irwin MR. Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram. Am J Geriatr Psychiatry. 2010;18:154-162.
43. Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999;175:17-22.
44. Davidson JR, Stein DJ, Rothbaum BO, et al. Resilience as a predictor of remission in PTSD patients treated with venlafaxine XR or placebo. Poster presented at: Annual Meeting of the Anxiety Disorders of America; March 23-26, 2006; Miami.
